The biotech start-up company TOLREMO therapeutics AG develops small molecule drugs that are combined with existing standard cancer therapies to prevent the development of resistance in tumour cells from the outset. The goal is to achieve a better response rate, longer survival and thus an improved quality of life for cancer patients.

In the course of the further development of the company, the vision, mission and overall appearance of the start-up were thoroughly revised in a communication strategy workshop. The aim was to better reach the various target groups with an updated web presence. Life Science Communication accompanied the strategy update and implemented the design and content of the new website.